Latest filing published 30 Mar 2021 for Agile Therapeutics INC, €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jason Butch: trading record in brief
All filings by Jason Butch on record concern Agile Therapeutics Inc. We count 2 filings; the first trade dates from 26 March 2021 and the latest from 29 March 2021.
Purchases make up the whole of the open-market record (2 purchases, €17k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 30 March 2021 with an open-market purchase (€15k) in Agile Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jason Butch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,642 shares@ US$2.0186.5% of flowCommon StockSEC:0001104659-21-043947:0Canonical exit: 24 Jun 2021 (T+90)
- 1,358 shares@ US$1.9913.5% of flowCommon StockSEC:0001104659-21-043947:1Canonical exit: 27 Jun 2021 (T+90)
2 of 2 declarations